Chih‐Wei Lin - Publications, H-index & Citations

Chih‐Wei Lin

amgen

13H指数

51论文数

1.6K被引数

收录论文 27

发表时间

Adjoint and Unrolled Automatic Differentiation for Laplace-Approximated Likelihoods in Population PK and PK/PD Models 用于群体PK和PK/PD模型中拉普拉斯近似似然函数的伴随与展开自动微分

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-16

OAAI

Guido H. Jajamovich; William Holmes; Chih-Wei Lin; Khamir Mehta

Context Engineering for AI-Assisted Pharmacometrics: A Practical Tutorial 人工智能辅助药代动力学和药效动力学的语境工程：一个实用教程

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-15

OAAI

Ari Pritchard-Bell; Chih-Wei Lin; William Holmes; Sameer Doshi

Application of Population-Based Meta-Heuristic Algorithms for Robust Initialization in Mechanistic Pharmacometric Modeling 基于群体的元启发式算法在机制药代动力学建模稳健初始化中的应用

CPT-Pharmacometrics & Systems Pharmacology

IF3

2026-09-15

OAAI

Dongjin Lee; Chih-Wei Lin

Integration of Time-Varying Pharmacometric Modeling With Cox Regression for Time-to-Event Analysis in NONMEM 将时变药代动力学模型与Cox回归集成用于NONMEM中的时间-事件分析

cpt: pharmacometrics & systems pharmacology

IF0

2026-04-23

OAAI

Chih-Wei Lin; Po-Wei Chen; Sameer Doshi; Sandeep Dutta

Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer 塔拉他单抗（Tarlatamab）的群体药代动力学研究，该药物是一种半衰期延长型DLL3靶向T细胞结合剂，用于治疗既往接受过治疗的小细胞肺癌患者。

CLINICAL PHARMACOKINETICS

IF4

2025-04-22

PREAI

Kong, Stephanie; Minocha, Mukul; Chen, Po-Wei; Martinez, Pablo; Anderson, Erik S.; Parkes, Amanda; Houk, Brett E.; Lin, Chih-Wei

Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRASG12C Mutation from Phase 1 and Phase 2 Studies

AAPS JOURNAL

IF3.7

2025-01-13

PREAI

Nagase, Mario; Houk, Brett; Vuu, Irene; Cardona, Panli; Dutta, Sandeep; Lin, Chih-Wei

A novel Bayesian generative approach for estimating tumor dynamics from published studies

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2024-05-22

OAAI

Pourzanjani, Arya; Modi, Saurabh; Connarn, Jamie; Zhang, Xinwen; Upreti, Vijay; Lin, Chih-Wei; Mehta, Khamir

A multistate platform model for time-to-event endpoints in oncology clinical trials

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2023-11-08

OAAI

Lin, Chih-Wei; Nagase, Mario; Doshi, Sameer; Dutta, Sandeep

Transthoracic dye-marking and intravenous fluorescence imaging for the margin in complex segmentectomy

ASIAN JOURNAL OF SURGERY

IF3.8

2022-02-01

OAAI

Kam, Kam-Hong; Lin, Chih-Wei; Gonzalez-Rivas, Diego; Chang, Jia-Ming

Glecaprevir/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial Glecaprevir/pibrentasvir治疗初治慢性HCV基因型1-6和代偿性肝硬化患者8周: EXPEDITION-8试验

JOURNAL OF HEPATOLOGY

IF33

2020-03-01

115

OAAI

Brown, Robert S., Jr.; Buti, Maria; Rodrigues, Lino; Chulanov, Vladimir; Chuang, Wan-Long; Aguilar, Humberto; Horvath, Gabor; Zuckerman, Elimelech; Carrion, Barbara Rosado; Rodriguez-Perez, Federico; Urbanek, Petr; Abergel, Armand; Cohen, Eric; Lovell, Sandra S.; Schnell, Gretja; Lin, Chih-Wei; Zha, Jiuhong; Wang, Stanley; Trinh, Roger; Mensa, Federico J.; Burroughs, Margaret; Felizarta, Franco

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

HEPATOLOGY

IF15.8

2019-08-13

OAAI

Jonas, Maureen M.; Squires, Robert H.; Rhee, Susan M.; Lin, Chih-Wei; Bessho, Kazuhiko; Feiterna-Sperling, Cornelia; Hierro, Loreto; Kelly, Deirdre; Ling, Simon C.; Strokova, Tatiana; del Valle-Segarra, Antonio; Lovell, Sandra; Liu, Wei; Ng, Teresa I.; Porcalla, Ariel; Gonzalez, Yuri Sanchez; Burroughs, Margaret; Sokal, Etienne

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

HEPATOLOGY

IF15.8

2018-04-01

113

OAAI

Poordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David; Hezode, Christophe; Felizarta, Franco; Reindollar, Robert W.; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih-Wei; Lei, Yang; Ng, Teresa I.; Krishnan, Preethi; Kopecky-Bromberg, Sarah; Kort, Jens; Mensa, Federico J.

Relationship Between Atrasentan Concentrations and Urinary Albumin to Creatinine Ratio in Western and Japanese Patients With Diabetic Nephropathy

CLINICAL THERAPEUTICS

IF3.6

2018-02-01

PREAI

Lin, Chih-Wei; Mostafa, Nael M.; Andress, Dennis L.; Brennan, John J.; Klein, Cheri E.; Awni, Walid M.

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2018-01-25

346

OAAI

Zeuzem, S.; Foster, G. R.; Wang, S.; Asatryan, A.; Gane, E.; Feld, J. J.; Asselah, T.; Bourliere, M.; Ruane, P. J.; Wedemeyer, H.; Pol, S.; Flisiak, R.; Poordad, F.; Chuang, W. -L.; Stedman, C. A.; Flamm, S.; Kwo, P.; Dore, G. J.; Sepulveda-Arzola, G.; Roberts, S. K.; Soto-Malave, R.; Kaita, K.; Puoti, M.; Vierling, J.; Tam, E.; Vargas, H. E.; Bruck, R.; Fuster, F.; Paik, S. -W.; Felizarta, F.; Kort, J.; Fu, B.; Liu, R.; Ng, T. I.; Pilot-Matias, T.; Lin, C. -W.; Trinh, R.; Mensa, F. J.

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

LANCET INFECTIOUS DISEASES

IF31

2017-10-01

267

PREAI

Forns, Xavier; Lee, Samuel S.; Valdes, Joaquin; Lens, Sabela; Ghalib, Reem; Aguilar, Humberto; Felizarta, Franco; Hassanein, Tarek; Hinrichsen, Holger; Rincon, Diego; Morillas, Rosa; Zeuzem, Stefan; Horsmans, Yves; Nelson, David R.; Yu, Yao; Krishnan, Preethi; Lin, Chih-Wei; Kort, Jens J.; Mensa, Federico J.

Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Taking Concomitant Proton Pump Inhibitors

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2017-10-01

PREAI

Flamm, Steven; Reddy, Rajender; Zadeikis, Neddie; Hassanein, Tarek; Bacon, Bruce; Maieron, Andreas; Zeuzem, Stefan; Bourliere, Marc; Luis Calleja, Jose; Oberoi, Rajneet; Lin, Chih-Wei; Lovell, Sandra; Semizarov, Dimitri; Mensa, Federico

Glecaprevir and Pibrentasvir for 12 Weeks for Hepatitis C Virus Genotype 1 Infection and Prior Direct-Acting Antiviral Treatment

HEPATOLOGY

IF15.8

2017-04-10

150

OAAI

Poordad, Fred; Felizarta, Franco; Asatryan, Armen; Sulkowski, Mark S.; Reindollar, Robert W.; Landis, Charles S.; Gordon, Stuart C.; Flamm, Steven L.; Fried, Michael W.; Bernstein, David E.; Lin, Chih-Wei; Liu, Ran; Lovell, Sandra S.; Ng, Teresa I.; Kort, Jens; Mensa, Federico J.

PHARMACOKINETICS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR IN ADULTS WITH CHRONIC GENOTYPE 1-6 HEPATITIS C VIRUS INFECTION AND COMPENSATED CIRRHOSIS: AN INTEGRATED ANALYSIS

GASTROENTEROLOGY

IF25.1

2017-04-01

PREAI

Gane, Edward; Poordad, Fred; Valdes, Joaquin M.; Lin, Chih-Wei; Liu, Wei; Asatryan, Armen; Wang, Stanley; Stedman, Catherine A.; Greenbloom, Susan; Nguyen, Tuan T.; Elkhashab, Magdy; Worns, Marcus-Alexander; Tran, Albert; Mulkay, Jean-Pierre; Yu, Yao; Porcalla, Ariel R.; Mensa, Federico

MAGELLAN-1, PART 2: GLECAPREVIR AND PIBRENTASVIR FOR 12 OR 16 WEEKS IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 AND PRIOR DIRECT-ACTING ANTIVIRAL TREATMENT FAILURE

GASTROENTEROLOGY

IF25.1

2017-04-01

PREAI

Poordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David R.; Hezode, Christophe; Lalezari, Jacob; Felizarta, Franco; Reindollar, Robert; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih-Wei; Lei, Yang; Ng, Teresa; Pilot-Matias, Tami; Kort, Jens; Mensa, Federico

EXPEDITION-I: EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR IN ADULTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1, 2, 4, 5 OR 6 INFECTION AND COMPENSATED CIRRHOSIS

GASTROENTEROLOGY

IF25.1

2017-04-01

PREAI

Forns, Xavier; Lee, Sam; Valdes, Joaquin M.; Lens, Sabela; Ghalib, Reem; Aguilar, Humberto; Felizarta, Franco; Hassanein, Tarek I.; Hinrichsen, Holger; Rincon, Diego; Morillas, Rosa M.; Zeuzem, Stefan; Horsmans, Yves; Nelson, David R.; Yu, Yao; Pilot-Matias, Tami; Lin, Chih-Wei; Mensa, Federico

研究方向